the pharmacokinetic of 5-fluorouracil and its permeation into malignant pleural effusion was investigated in 9 patients with breast carcinoma who received 600 mg/m2 5-fluorouracil i.v . within the cmf protocol .
C0016360
fluorouracil
C0055981
cmf protocol